Leyland-Jones B: Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases, N Engl J Med, vol.344, pp.5278-5286, 2001. ,
Pharmacokinetics, safety, and efficacy of trastuzumab administered every three weeks in combination with paclitaxel, J Clin Oncol, vol.21, pp.3965-3971, 2003. ,
Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer, Br J Cancer, vol.81, pp.1419-1425, 1999. ,
Trastuzumab in CSF, J Clin Oncol, vol.18, pp.2349-2351, 2000. ,
Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer, Oncol Rep, vol.15, pp.1373-1377, 2006. ,
High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer, Ann Oncol, vol.19, 1978. ,
, vitro models of the blood-brain barrier
, Acta Neurobiol Exp (Wars), vol.71, pp.113-128, 2011.
Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier, Nat Rev Immunol, vol.114, pp.715-725, 2001. ,
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration, Ophthalmology, vol.112, pp.1048-1053, 2005. ,
Ranibizumab for neovascular age-related macular degeneration, N Engl J Med, vol.355, pp.1419-1431, 2006. ,
Safety and pharmacokinetic analysis of methotrexate administered directly into the fourth ventricle in a piglet model, J Neurooncol, vol.100, pp.397-406, 2010. ,
Pharmacokinetic analysis of etoposide distribution after administration directly into the fourth ventricle in a piglet model, J Neurooncol, vol.97, pp.25-32, 2010. ,